Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × midostaurin × Myeloid × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 6 Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Myeloid 1 Lymphoid 1

Conditions

Mastocytosis, Systemic 1 Leukemia, Myeloid, Acute 1 Leukemia, Mast-Cell 1

Interventions

nilotinib 3 ruxolitinib 2 venetoclax 1 selinexor 1 ponatinib 1 navitoclax 1 midostaurin 1 fludarabine phosphate 1 asciminib 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05219266 2024-06-28

Managed Access Programs for PKC412, Midostaurin

Novartis

No longer available

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Leukemia, Myeloid, Acute, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡